U.S. Residential REITs Stock News

NasdaqGS:DYN
NasdaqGS:DYNBiotechs

The Bull Case For Dyne Therapeutics (DYN) Could Change Following FDA Clearance Of DYNE-302 Trial

In July 2026, Dyne Therapeutics, Inc. reported a wider second-quarter net loss of US$178.56 million, or US$1.08 per share, alongside FDA clearance to begin a Phase 1 trial of DYNE-302 for facioscapulohumeral muscular dystrophy. This marks Dyne’s third clinical program built on its FORCE platform and targets a rare muscle disease with no approved therapies, highlighting the company’s focus on genetically defined neuromuscular conditions. With this new FDA-cleared Phase 1 trial for DYNE-302,...
NasdaqGS:STGW
NasdaqGS:STGWMedia

How Investors Are Reacting To Stagwell (STGW) Q2 Loss, Buybacks, And Governance Shake-Up

Stagwell Inc. reported its second-quarter 2026 results, with sales rising to US$786.31 million while net loss widened to US$8.12 million, and also outlined plans for a more organic-growth-led second half supported by selective acquisitions, stock buybacks, and capital investments. Alongside these results, Stagwell moved to strengthen its governance by appointing independent director Beth J. Kaplan to the board, signaling continued attention to board independence as the company refines its...
NasdaqGS:DGII
NasdaqGS:DGIICommunications

Is Digi International (DGII) Fully Valued On Strong Earnings And Higher 2026 Guidance?

Why Digi International Stock Is Back In Focus After Fresh Earnings Digi International (DGII) is on investors' radar after reporting third quarter 2026 results and updating its outlook. The company posted higher revenue, net income and earnings per share for both the quarter and nine month period. The company reported third quarter revenue of US$138.67 million compared with US$107.51 million a year earlier. Net income for the quarter was US$15.74 million versus US$10.24 million, with basic...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

3 Shipping Stocks Worth Watching As Strait Of Hormuz Disruption Reshapes Trade

The Strait of Hormuz standoff has turned a vital shipping lane into a pressure point for global markets, with oil prices jumping around 5% as supply routes stay disrupted. That kind of shock can quickly reshape which stocks investors crowd into and which they avoid. This article looks at three stocks from the Global Shipping and Marine Transport Stocks screener that are closely tied to this story and explains how the same headlines can mean very different outcomes for each one. The three...
NYSE:NOV
NYSE:NOVEnergy Services

Why Did NOV (NOV) Shares Move Today?

NOV (NOV) shares moved after the company reported second quarter 2026 results that showed net income of US$112 million on US$2,134 million in sales, alongside guidance for third quarter revenues to be flat to up 2% year over year. See our latest analysis for NOV. The latest earnings release appears to have reinforced interest in NOV, with the share price at US$20.70 and a 1 month share price return of 9.58%. Over the past year, the stock has delivered a 78.45% total shareholder return, which...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

NetScout Systems (NTCT) Is Down 5.6% After Earnings Rebound And Reaffirmed Fiscal 2027 Outlook

In early August 2026, NetScout Systems, Inc. reported past first-quarter results showing revenue of US$210.42 million versus US$186.75 million a year earlier, with net income improving to US$21.84 million from a prior net loss. The company also reaffirmed its fiscal 2027 guidance for revenue between US$885.0 million and US$915.0 million and GAAP diluted EPS of US$1.55–US$1.70, underscoring management’s confidence in the business trajectory despite prior-year losses. We’ll now examine how...
NYSE:ED
NYSE:EDIntegrated Utilities

Is Stronger 2026 Profitability Altering The Investment Case For Consolidated Edison (ED)?

Consolidated Edison, Inc. reported past second-quarter 2026 results, with revenue of US$4,069 million and net income of US$308 million, both higher than a year earlier, while earnings per share from continuing operations rose to US$0.83 basic and diluted. For the first half of 2026, the company’s revenue increased to US$9,164 million and net income to US$1,232 million, pointing to stronger profitability from its ongoing operations compared with the same period of the previous year. With...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Faster Revenue Growth With Wider Losses Might Change The Case For Investing In Axsome (AXSM)

Axsome Therapeutics, Inc. recently reported second-quarter 2026 results, with revenue rising to US$218.38 million from US$150.04 million a year earlier, while net loss widened to US$51.31 million and basic loss per share from continuing operations was US$0.99. Despite strong year-over-year revenue growth across both the quarter and first half of 2026, Axsome’s net losses and loss per share both increased, underscoring the cost of its expanding CNS portfolio and commercialization efforts. We...
NasdaqGS:LQDT
NasdaqGS:LQDTCommercial Services

Liquidity Services (LQDT) Gains On Strong Results But Is The Valuation Already Priced In

Why Liquidity Services Stock Is Back On Investor Radars Liquidity Services (LQDT) has drawn fresh attention after reporting third quarter and nine month results to June 30, 2026, alongside new guidance for the upcoming quarter that outlines expected net income and earnings per share. See our latest analysis for Liquidity Services. The latest results and guidance appear to have fed into a strong run for Liquidity Services, with the share price at $40.91 and a 90 day share price return of...
NYSE:WMB
NYSE:WMBOil and Gas

How Investors May Respond To Williams (WMB) Earnings Beat, Dividend Hike and Big-Ticket Growth Moves

In the past week, Williams Companies reported second-quarter 2026 results showing revenue of US$3,053 million and net income of US$827 million, with basic and diluted earnings per share from continuing operations of US$0.68, and also announced a quarterly dividend increase to US$0.525 per share, or US$2.10 annualized. Alongside higher earnings and a larger dividend, Williams advanced its Socrates Power Innovation project, completed the US$5.50 billion Momentum Midstream acquisition, and...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Broadcom (AVGO) AI Push Keeps Valuation In Focus

Broadcom (AVGO) is back in focus after announcing new AI driven security upgrades to VMware vDefend and Avi Load Balancer, alongside strong AI semiconductor momentum tied to custom chips for large hyperscale customers. See our latest analysis for Broadcom. Broadcom's recent AI security updates and custom chip wins come after a strong run, with a year to date share price return of 21.51% and a 1 year total shareholder return of 40.01%, while the 3 year total shareholder return is over 4x. If...
NasdaqGS:CRSR
NasdaqGS:CRSRTech

AI Stocks Retail Investors Are Watching As Enterprise Software Spending Shifts

AI and tech related earnings updates are back in focus, with companies such as Applied Materials and Cisco under close watch for how much capital is now flowing into artificial intelligence infrastructure. This wave of spending interest puts stocks tied to chips, cloud and software in the spotlight. This article highlights three stocks from the Artificial Intelligence Stocks screener that sit at the heart of this shift and explains what makes each one stand out. The three companies featured...
NasdaqGS:BAND
NasdaqGS:BANDTelecom

Bandwidth (BAND) Lifted Guidance, Is The Upside Already Priced In?

Bandwidth (BAND) drew investor attention after its latest earnings report on July 29, 2026, which highlighted year-over-year revenue growth, a move from loss to profit, and higher full year revenue guidance. See our latest analysis for Bandwidth. The earnings release and raised guidance on July 29, 2026 come after a sharp recent pullback, with a 30-day share price return of a 30.17% decline. However, momentum over the longer term has been stronger, as the year-to-date share price return is...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued

Recent momentum in NovoCure (NVCR) stock has been closely tied to renewed optimism around its tumor treating fields devices and the possibility of upcoming FDA approval, which has kept investor attention firmly on the company. See our latest analysis for NovoCure. That optimism has fed into a strong short term trend for NovoCure, with a 1 day share price return of 5.61% and a 7 day share price return of 12.99%. The 1 year total shareholder return sits at 58.81%, despite a 3 year total...
NYSE:STNG
NYSE:STNGOil and Gas

Scorpio Tankers (STNG) Gains Attention As Earnings, Dividend And Buybacks Meet Fair Value Debate

Earnings, Dividend, and Buybacks Put Scorpio Tankers in Focus Scorpio Tankers (STNG) has drawn fresh attention after its second quarter 2026 update, which combined higher net income and earnings per share with a declared cash dividend and further progress on share repurchases. The company reported second quarter net income of US$387.54 million and basic earnings per share from continuing operations of US$8.47. For the first half of 2026, net income reached US$603.8 million, with basic...
NasdaqGS:BANF
NasdaqGS:BANFBanks

BancFirst (BANF) Faces A Valuation Test As Short Term Momentum Softens

BancFirst stock performance snapshot BancFirst (BANF) has attracted attention after a period of mixed share performance, with the stock down about 1.5% over the past month but up roughly 2.1% over the past 3 months. For longer term holders, BancFirst shows a year to date gain of about 5.5%, while the 1 year total return is down roughly 5.3%. Over 3 years and 5 years, total returns are about 21.4% and 112.0% respectively. See our latest analysis for BancFirst. At a share price of $112.29,...
NYSE:STAG
NYSE:STAGIndustrial REITs

How Investors May Respond To STAG Industrial (STAG) EPS Uptick And Affirmed Dividend Amid Softer H1

STAG Industrial, Inc. reported past second-quarter 2026 results showing sales of US$223.53 million and net income of US$52.92 million, alongside affirming a third-quarter cash dividend of US$0.3875 per share. While quarterly earnings per share edged up year over year, net income for the first half of 2026 trailed the prior year, highlighting a contrast between recent momentum and earlier-period pressure. With quarterly earnings per share improving and the dividend affirmed, we’ll now examine...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Revolution Medicines (RVMD) BeOne Deal Puts Its Valuation Back In Focus

Revolution Medicines (RVMD) drew fresh attention on 10 August 2026 after announcing a multi-part collaboration with BeOne Medicines. The agreement combines joint clinical development and regional rights for key RAS(ON) oncology assets. See our latest analysis for Revolution Medicines. The collaboration news comes after a strong period for Revolution Medicines’ share price, with a 42.03% 90-day share price return and an even larger 1-year total shareholder return that indicates strong momentum...
NYSE:COHR
NYSE:COHRElectronic

Intel Stock Drop Puts 3 AI Infrastructure Shares On Retail Investors Radar

Intel’s US$15b stock offering has pushed fresh attention onto capital intensive growth, where huge spending on factories, chips, and infrastructure can reshape future earnings power. A 4% pre market drop in Intel shares has some investors worried, while others see potential openings across related large cap stocks. This article walks through 3 companies that sit in the crosshairs of this AI driven capex story. The three stocks covered below are just a starting sample, since the full US...
NYSE:TDS
NYSE:TDSWireless Telecom

The Bull Case For Telephone and Data Systems (TDS) Could Change Following Q2 Earnings Surge And Higher Fiber Targets - Learn Why

In the past week, Telephone and Data Systems, Inc. reported Q2 2026 results showing revenue of US$309.28 million and net income of US$298.37 million, alongside a swing from a per-share loss to earnings of over US$2.40 on a diluted basis. Management also reported strong progress in fiber build-out and raised 2026 fiber address delivery guidance, even as legacy copper and cable services weighed on telecom revenue expectations. Now we’ll examine how this earnings surge, alongside upgraded fiber...
NYSE:TRIN
NYSE:TRINCapital Markets

Is Trinity Capital (TRIN) Overvalued As Revenue Rises But EPS Falls?

Why Trinity Capital Earnings Matter For Shareholders Trinity Capital (TRIN) just reported second quarter 2026 results that showed higher revenue and net income than a year ago, while earnings per share from continuing operations moved in the opposite direction. The company posted second quarter revenue of US$87.17 million and net income of US$44.41 million, compared with US$69.48 million and US$41.41 million in the prior year period. Basic and diluted EPS from continuing operations were...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance

Why Bruker stock is back in focus after the latest quarterly update Bruker (BRKR) is back on investors’ radar after second quarter results combined rising sales with a reported net loss driven largely by impairment charges. Fresh 2026 revenue guidance added another key data point for the stock. See our latest analysis for Bruker. Bruker’s latest guidance for 2026, combined with the second quarter impairment charges, has come alongside a 25.91% 90 day share price return and an 83.88% 1 year...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

Perella Weinberg Partners (PWP) Beat Expectations, Is The Premium Valuation Already Priced In?

How the latest earnings event shapes the Perella Weinberg Partners story Perella Weinberg Partners (PWP) just reported second quarter 2026 earnings that came in ahead of analyst expectations, with management pointing to a surge in announced transactions and increased client activity across key sectors. Alongside the earnings release, the company confirmed a quarterly dividend and detailed a series of partner promotions. These moves provide several concrete data points to consider when...
NYSE:AORT
NYSE:AORTMedical Equipment

Artivion (AORT) Revenue Rose As Losses Emerged, Is It Still 37% Below Fair Value?

Key earnings details from Artivion’s latest quarter Artivion (AORT) released second quarter and first half 2026 results that paired higher revenue with a move to loss making performance. This mix of growth and red ink is central to the current stock debate. See our latest analysis for Artivion. Artivion’s latest earnings release and upcoming conference appearance arrive after a mixed period, with the share price falling year to date but three year total shareholder return still positive. This...